双等位CFTR突变不育男性的男科特征:德奥多中心71例研究
该多中心研究分析了德国和奥地利71例携带双等位CFTR突变的不育男性,发现99%表现为无精子症,仅18%经触诊和超声诊断先天性双侧输精管缺如(CBAVD),39%输精管双侧正常。研究建议对促性腺激素水平正常的特发性无精子症男性均应行CFTR突变分析,而不仅限于输精管缺如者。
要点
- 双等位CFTR突变不育男性中99%为无精子症,但仅18%确诊CBAVD。
- 39%患者输精管双侧正常,提示CFTR突变分析指征应扩大。
- 促性腺激素正常的不明原因无精子症男性推荐行CFTR突变分析。
核心结论
- CFTR突变分析指征应超越输精管缺如,覆盖促性腺激素正常的不明原因无精子症男性。
研究设计与样本
- 多中心研究,纳入德国和奥地利71例携带双等位CFTR突变的成年不育男性,至少有一次精液分析结果。
主要发现
- 70/71(99%)患者为无精子症,1例为严重少精子症<0.1×10^6/ml。
- 22%患者睾酮值降低,促性腺激素(FSH、LH)水平正常。
- 平均右侧睾丸体积23.38 ml(SD 8.77),左侧22.59 ml(SD 8.68),较正常显著增大(P < 0.01),但均值仍在12-25 ml参考范围内。
- 精液量、pH、α-葡萄糖苷酶和果糖四项参数显著降低(P < 0.01)。
- 仅18%经触诊和超声诊断CBAVD,31%诊断不确定,12%输精管发育不良,39%输精管双侧正常。
关键数值与推荐
- 推荐对所有促性腺激素水平正常的不明原因无精子症男性行CFTR突变分析。
- 怀疑梗阻性无精子症时建议对CFTR基因进行完整测序。
临床怎么用
- 对促性腺激素正常的不明原因无精子症男性,应扩展CFTR突变检测,不局限于输精管缺如者。
- 怀疑梗阻性无精子症时,行CFTR基因完整测序以指导辅助生殖决策。
局限性
- 多数患者未通过家系分离研究正式确认变异的反式位置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: When should cystic fibrosis transmembrane conductance regulator (CFTR) mutation analysis be recommended in infertile men based on andrological findings? SUMMARY ANSWER: CFTR mutation analysis is recommended in all men with unexplained azoospermia in the presence of normal gonadotropin levels. WHAT IS KNOWN ALREADY: While 80-97% of men with congenital bilateral absence of the vas deferens (CBAVD) are thought to carry CFTR mutations, there is uncertainty about the spectrum of clinical and andrological abnormalities in infertile men with bilallelic CFTR mutations. This information is relevant for evidence-based recommendations to couples requesting assisted reproduction. STUDY DESIGN, SIZE, DURATION: We studied the andrological findings of patients with two CFTR mutations who were examined in one of the cooperating fertility centres in Germany and Austria. In the period of January till July 2019, the completed and anonymized data sheets of 78 adult male patients were returned to and analysed by the project leader at the Institute of Human Genetics in Innsbruck, Austria. PARTICIPANTS/MATERIALS, SETTING, METHODS: Minimum study entry criteria were the presence of two (biallelic) CFTR mutations and results of at least one semen analysis. Andrological assessments were undertaken by standardized data sheets and compared with normal reference values. Seventy-one patients were eligible for the study (n = 30, 42% from Germany, n = 26, 37% from Austria, n = 15, 21% other nations). MAIN RESULTS AND THE ROLE OF CHANCE: Gonadotropin levels (FSH, LH) were normal, 22% of patients had reduced testosterone values. Mean right testis volume was 23.38 ml (SD 8.77), mean left testis volume was 22.59 ml (SD 8.68) and thereby statistically increased compared to normal (P < 0.01). although the means remained in the reference range of 12-25 ml. Semen analysis revealed azoospermia in 70 of 71 (99%) patients and severe oligozoospermia <0.1 × 106/ml in one patient. Four semen parameters, i.e. ejaculate volume, pH, α-glucosidase and fructose values, were significantly reduced (P < 0.01). Only 18% of patients had a palpatory and sonographically diagnosed CBAVD, while in 31% the diagnosis of CBAVD was uncertain, in 12% patients, the vas deferens was present but hypoplastic, and in 39% the vas deferens was normally present bilaterally. Seminal vesicles were not detectable in 37% and only unilaterally present in 37% of patients. Apart from total testes volume, clinical findings were similar in patients with two confirmed pathogenic CFTR mutations (Group I) compared with patients who carried one pathogenic mutation and one CFTR variant of unknown significance (Group II). LIMITATIONS, REASONS FOR CAUTION: We could not formally confirm the in trans position of genetic variants in most patients as no family members were available for segregation studies. Nonetheless, considering that most mutations in our study have been previously described without other rare variants in cis, and in view of the compatible andrological phenotype, it is reasonable to assume that the biallelic genotypes are correct. WIDER IMPLICATIONS OF THE FINDINGS: Our study reveals that CFTR mutation analysis has a broader indication than just the absence of the vas deferens. We recommend to completely sequence the CFTR gene if there is a suspicion of obstructive azoospermia, and to extend this analysis to all patients with unexplained azoospermia in the presence of normal gonadotropin levels. STUDY FUNDING/COMPETING INTEREST(S): German Research Foundation Clinical Research Unit 'Male Germ Cells: from Genes to Function' (DFG CRU326, grants to F.T.). There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Rudnik-Schöneborn S, Messner M, Vockel M, et al. Andrological findings in infertile men with two (biallelic) CFTR mutations: results of a multicentre study in Germany and Austria comprising 71 patients. Hum Reprod. 2021. PMID: 33374015. doi:10.1093/humrep/deaa348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。